Planet Labs PBC (PL) 10-Q 9 Jun 23 2024 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Apr. 30, 2023	Jun. 01, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2023
Document Transition Report	false
Entity File Number	001-40166
Entity Registrant Name	Planet Labs PBC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-4299396
Entity Address, Address Line One	645 Harrison Street
Entity Address, Address Line Two	Floor 4
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94107
City Area Code	415
Local Phone Number	829-3313
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001836833
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--01-31
Common Class A
Document Information [Line Items]
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	PL
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		254,874,130
Warrant
Document Information [Line Items]
Title of 12(b) Security	Warrants to purchase Class A common stock, at an exercise price of $11.50 per share
Trading Symbol	PL WS
Security Exchange Name	NYSE
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		21,157,586

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands		Apr. 30, 2023	Jan. 31, 2023
Current assets
Cash and cash equivalents		$ 140,763	$ 181,892
Short-term investments		235,415	226,868
Accounts receivable, net of allowance of $1,299 and $1,289, respectively		39,072	38,952
Prepaid expenses and other current assets		19,275	27,943
Total current assets		434,525	475,655
Property and equipment, net		118,193	108,091
Capitalized internal-use software, net		11,878	11,417
Goodwill		112,748	112,748
Intangible assets, net		13,999	14,831
Restricted cash and cash equivalents, non-current		5,660	5,657
Operating lease right-of-use assets		23,697	20,403
Other non-current assets		2,757	3,921
Total assets		723,457	752,723
Current liabilities
Accounts payable		14,657	6,900
Accrued and other current liabilities	[1]	34,432	46,022
Deferred revenue	[1]	44,620	51,900
Liability from early exercise of stock options		11,653	12,550
Operating lease liabilities, current		6,320	4,885
Total current liabilities		111,682	122,257
Deferred revenue	[1]	2,474	2,882
Deferred hosting costs	[1]	10,671	8,679
Public and private placement warrant liabilities		10,725	16,670
Operating lease liabilities, non-current		19,912	17,145
Contingent consideration		7,142	7,499
Other non-current liabilities		1,502	1,487
Total liabilities		164,108	176,619
Commitments and contingencies (Note 8)
Stockholders’ equity
Common stock, $0.0001 par value, 570,000,000, 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at April 30, 2023 and January 31, 2023, 252,542,296 and 250,625,975 Class A shares issued and outstanding at April 30, 2023 and January 31, 2023, respectively, 21,157,586 Class B shares issued and outstanding at April 30, 2023 and January 31, 2023, 0 Class C shares issued and outstanding at April 30, 2023 and January 31, 2023 (1)		27	27
Additional paid-in capital		1,531,380	1,513,102
Accumulated other comprehensive income		1,682	2,271
Accumulated deficit		(973,740)	(939,296)
Total stockholders’ equity		559,349	576,104
Liabilities and Equity		$ 723,457	$ 752,723
[1]Balance includes related-party transactions entered into with Google, LLC (“Google”). See Note 10.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Accounts receivable, allowance	$ 1,299	$ 1,289
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common Class A
Common stock, shares authorized (in shares)	570,000,000	570,000,000
Common stock, shares issued (in shares)	252,542,296	250,625,975
Common stock, shares outstanding (in shares)	252,542,296	250,625,975
Common Class B
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	21,157,586	21,157,586
Common stock, shares outstanding (in shares)	21,157,586	21,157,586
Common Class C
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Apr. 30, 2023	Apr. 30, 2022
Income Statement [Abstract]
Revenue	[1]	$ 52,703	$ 40,127
Cost of revenue	[1]	24,556	23,628
Gross profit		28,147	16,499
Operating expenses
Research and development	[1]	28,186	24,750
Sales and marketing		23,125	18,855
General and administrative		21,528	20,608
Total operating expenses		72,839	64,213
Loss from operations		(44,692)	(47,714)
Interest income		4,506	112
Change in fair value of warrant liabilities		(5,945)	(3,276)
Other income (expense), net		104	280
Total other income (expense), net		10,555	3,668
Loss before provision for income taxes		(34,137)	(44,046)
Provision for income taxes		307	314
Net loss		$ (34,444)	$ (44,360)
Basic and diluted net loss per share attributable to common stockholders, basic (in dollars per share)		$ (0.13)	$ (0.17)
Basic and diluted net loss per share attributable to common stockholders, diluted (in dollars per share)		$ (0.13)	$ (0.17)
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders, basic (in shares)		272,347,977	264,088,997
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders, diluted (in shares)		272,347,977	264,088,997
[1]Balance includes related-party transactions entered into with Google. See Note 10.

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (34,444)	$ (44,360)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	(45)	175
Change in fair value of available-for-sale securities	(544)	0
Other comprehensive income (loss), net of tax	(589)	175
Comprehensive loss	$ (35,033)	$ (44,185)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jan. 31, 2022			262,175,273
Beginning balance at Jan. 31, 2022	$ 648,245	$ (301)	$ 27	$ 1,423,151	$ 2,096	$ (777,029)	$ (301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)			3,524,182
Issuance of Class A common stock from the exercise of common stock options	6,203			6,203
Vesting of early exercised stock options (in shares)			215,178
Vesting of early exercised stock options (in shares)			91,911
Vesting of early exercised stock options	896			896
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)			(75,442)
Class A common stock withheld to satisfy employee tax withholding obligations	(411)			(411)
Stock-based compensation	20,259			20,259
Change in fair value of available-for-sale securities	0
Foreign currency translation adjustment	175				175
Net loss	(44,360)					(44,360)
Ending balance (in shares) at Apr. 30, 2022			265,931,102
Ending balance at Apr. 30, 2022	630,706		$ 27	1,450,098	2,271	(821,690)
Beginning balance (in shares) at Jan. 31, 2023			271,783,561
Beginning balance at Jan. 31, 2023	$ 576,104		$ 27	1,513,102	2,271	(939,296)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock from the exercise of common stock options (in shares)	1,018,385		1,018,385
Issuance of Class A common stock from the exercise of common stock options	$ 3,295			3,295
Vesting of early exercised stock options (in shares)			1,278,161
Vesting of early exercised stock options (in shares)			91,911
Vesting of early exercised stock options	896			896
Class A common stock withheld to satisfy employee tax withholding obligations (in shares)			(472,136)
Class A common stock withheld to satisfy employee tax withholding obligations	(1,896)			(1,896)
Stock-based compensation	15,983			15,983
Change in fair value of available-for-sale securities	(544)				(544)
Foreign currency translation adjustment	(45)				(45)
Net loss	(34,444)					(34,444)
Ending balance (in shares) at Apr. 30, 2023			273,699,882
Ending balance at Apr. 30, 2023	$ 559,349		$ 27	$ 1,531,380	$ 1,682	$ (973,740)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Operating activities
Net loss	$ (34,444)	$ (44,360)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	10,248	11,625
Stock-based compensation, net of capitalized cost of $627 and $437, respectively	15,356	19,822
Change in fair value of warrant liabilities	(5,945)	(3,276)
Change in fair value of contingent consideration	(423)	0
Other	(1,634)	504
Changes in operating assets and liabilities
Accounts receivable	(121)	19,982
Prepaid expenses and other assets	2,770	(403)
Accounts payable, accrued and other liabilities	(10,713)	(3,712)
Deferred revenue	(7,765)	(6,947)
Deferred hosting costs	2,070	231
Net cash used in operating activities	(30,601)	(6,534)
Investing activities
Purchases of property and equipment	(6,336)	(2,861)
Capitalized internal-use software	(739)	(645)
Maturities of available-for-sale securities	30,000	0
Purchases of available-for-sale securities	(35,229)	0
Other	(277)	(146)
Net cash used in investing activities	(12,581)	(3,652)
Financing activities
Proceeds from the exercise of common stock options	3,295	4,963
Class A common stock withheld to satisfy employee tax withholding obligations	(1,896)	(411)
Net cash provided by financing activities	1,399	4,552
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents	177	(649)
Net decrease in cash and cash equivalents, and restricted cash and cash equivalents	(41,606)	(6,283)
Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period	188,076	496,814
Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period	$ 146,470	$ 490,531

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Statement of Cash Flows [Abstract]
Share-based payment arrangement, capitalized costs	$ 627	$ 437

Organization

Organization	3 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Planet Labs PBC (“Planet,” or the “Company”) was founded to design, construct, and launch constellations of satellites with the intent of providing high cadence geospatial data delivered to customers via an online platform. The Company’s mission is to use space to help life on Earth, by imaging the world every day and making global change visible, accessible, and actionable. The Company is headquartered in San Francisco, California, with operations throughout the United States ( “ U.S.”), Canada, Asia and Europe. On July 7, 2021, Planet Labs Inc. (“Former Planet”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with dMY Technology Group, Inc. IV (“dMY IV”), a special purpose acquisition company (“SPAC”) incorporated in Delaware on December 15, 2020, Photon Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of dMY IV (“First Merger Sub”), and Photon Merger Sub Two, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of dMY IV (“Second Merger Sub”). Pursuant to the Merger Agreement, upon the favorable vote of dMY IV’s stockholders on December 3, 2021, on December 7, 2021, First Merger Sub merged with and into Former Planet (the “Surviving Corporation”), with Former Planet surviving the merger as a wholly owned subsidiary of dMY IV (the “First Merger”), and pursuant to Former Planet’s election immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation merged with and into dMY IV, with dMY IV surviving the merger (the “Business Combination”). Following the completion of the Business Combination, dMY IV was renamed Planet Labs PBC.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three months ended April 30, 2023 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2024 or any other future period. The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31. Certain notes or other information that are normally required by U.S. GAAP have been condensed or omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2023 (the “2023 Form 10-K”). Liquidity Since its inception, the Company has incurred net losses and negative cash flows from operations. The Company expects to incur additional operating losses and negative cash flows from operations as it seeks to expand its business. As of April 30, 2023 and January 31, 2023, the Company had $140.8 million and $181.9 million of cash and cash equivalents, respectively. Additionally, as of April 30, 2023 and January 31, 2023, the Company had short-term investments of $235.4 million and $226.9 million, respectively, which are highly liquid in nature and available for current operations. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, allowances for credit losses for available-for-sale debt securities and accounts receivable, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, assumptions used to measure stock-based compensation, the fair value of warrants, the fair value of assets acquired, and liabilities assumed from business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material to the unaudited condensed consolidated financial statements. Due to the COVID-19 Coronavirus pandemic (“COVID-19” or “COVID-19 pandemic”), and current events involving Russia and Ukraine, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur, and additional information is obtained. Segments Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. See Note 3, Revenue , for revenue by geographic region. See Note 6, Balance Sheet Components , for long-lived assets by geographic region. Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with or held by financial institutions in the U.S., Canada, Germany, the Netherlands and Singapore. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits. The maximum amount of loss at April 30, 2023 that the Company would incur if parties to cash, cash equivalents, and short-term investments failed completely to perform according to the terms of the contracts is $374.9 million. Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. As of April 30, 2023, one customer accounted for 17% of accounts receivable. As of January 31, 2023, one customer accounted for 15% of accounts receivable. For the three months ended April 30, 2023, one customer accounted for 21% of revenue. For the three months ended April 30, 2022, two customers accounted for 11% and 10% of revenue. The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations. The Company contracts with certain third-party service providers to launch satellites. Service providers who provide these services are limited. The inability of launch service providers to contract with the Company could materially impact future operating results. Significant Accounting Policies The Company’s significant accounting policies are included in Note 2 of its Consolidated Financial Statements included in the 2023 Form 10-K.

Revenue

Revenue	3 Months Ended
	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Deferred Revenue During the three months ended April 30, 2023 and 2022, the Company recognized revenue of $25.1 million and $22.6 million, respectively, that had been included in deferred revenue as of January 31, 2023 and January 31, 2022, respectively. Remaining Performance Obligations The Company often enters into multi-year imagery licensing arrangements with its customers, whereby the Company generally invoices the amount for the first year of the contract at signing followed by subsequent annual invoices at the anniversary of each year. Remaining performance obligations represent the amount of contracted future revenue that has not yet been recognized, which includes both deferred revenue and non-cancelable contracted revenue that will be invoiced and recognized in revenue in future periods. The Company’s remaining performance obligations were $138.0 million as of April 30, 2023, which consists of both deferred revenue of $47.1 million and non-cancelable contracted revenue that will be invoiced in future periods of $90.9 million. The Company expects to recognize approximately 80% of the remaining performance obligation over the next 12 months, approximately 99% of the remaining obligation over the next 24 months, and the remainder thereafter. Remaining performance obligations do not include unexercised contract options, firm orders where funding has not been appropriated and contracts which provide the customer with a right to terminate for convenience without incurring a substantive termination penalty. Disaggregation of Revenue The following table disaggregates revenue by major geographic region: Three Months Ended April 30, (in thousands) 2023 2022 United States $ 23,127 $ 18,752 Rest of World 29,576 21,375 Total revenue $ 52,703 $ 40,127 No single country in the Rest of World accounted for more than 10% of revenue for the three months ended April 30, 2023 and 2022. Costs to Obtain and Fulfill a Contract Commissions paid to the Company’s direct sales force are considered incremental costs of obtaining a contract with a customer. Accordingly, commissions are capitalized when incurred and amortized to sales and marketing expense over the period of benefit from the underlying contracts. The period of benefit from the underlying contract is consistent with the timing of transfer to the performance obligations to which the capitalized costs relate, and is generally consistent with the contract term. During the three months ended April 30, 2023 and 2022, the Company deferred $0.2 million and $0.5 million of commission expenditures to be amortized in future periods, respectively. The Company’s amortization of commission expenditures was $0.6 million and $0.3 million for the three month periods ended April 30, 2023 and 2022, respectively. As of April 30, 2023 and January 31, 2023, deferred commissions consisted of the following: (in thousands) April 30, 2023 January 31, 2023 Deferred commission, current $ 2,310 $ 2,405 Deferred commission, non-current 1,942 2,206 Total deferred commission $ 4,252 $ 4,611 The current portion of deferred commissions are included in prepaid expenses and other current assets on the condensed consolidated balance sheets. The non-current portion of deferred commissions are included in other non-current assets on the condensed consolidated balance sheets.

Fair Value of Financial Assets

Fair Value of Financial Assets and Liabilities	3 Months Ended
	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value of Financial Assets and Liabilities	Fair Value of Financial Assets and LiabilitiesAssets and liabilities recognized or disclosed at fair value in the financial statements are categorized based upon the level of judgment associated with the inputs used to measure their respective fair values. The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis for recognition or disclosure purposes as of April 30, 2023 and January 31, 2023 by level within the fair value hierarchy. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability. April 30, 2023 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds 90,136 — — U.S. Treasury securities 990 — — Restricted cash equivalents: money market funds 5,486 — — Short-term investments: U.S. Treasury securities 73,355 — — Commercial paper — 9,435 — Corporate bonds — 140,597 — U.S. government agency securities — 12,028 — Total assets $ 169,967 $ 162,060 $ — Liabilities Public Warrants 4,347 — — Private Placement Warrants — — 6,378 Contingent consideration for acquisition of business — — 7,607 Total liabilities $ 4,347 $ — $ 13,985 January 31, 2023 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds 72,382 — — Commercial paper — 999 — Restricted cash equivalents: money market funds 5,486 — — Short-term investments: U.S. Treasury securities 59,433 — — Commercial paper — 19,849 — Corporate bonds — 139,589 — U.S. government agency securities — 7,997 — Total assets $ 137,301 $ 168,434 $ — Liabilities Public Warrants 6,969 — — Private Placement Warrants — — 9,701 Contingent consideration for acquisition of business — — 8,030 Total liabilities $ 6,969 $ — $ 17,731 The fair value of cash held in banks and accrued liabilities approximate the stated carrying value due to the short time to maturity and are excluded from the tables above. Money Market Funds The fair value of the Company’s money market funds is based on quoted active market prices for the funds and is determined using the market approach. There were no realized or unrealized gains or losses on money market funds for the three months ended April 30, 2023 and 2022. Short-term Investments The fair value of the Company’s short-term investments classified within Level 2 are valued using third-party pricing services. The pricing services utilize industry standard valuation models. Inputs utilized include market pricing based on real-time trade data for the same or similar securities and other significant inputs derived from or corroborated by observable market data. Public and Private Placement Warrants The Public Warrants are classified within Level 1 as they are publicly traded and had an observable market price in an active market. The Private Placement Warrants (excluding the Private Placement Vesting Warrants) were valued based on a Black-Scholes option pricing model. Due to the market condition vesting requirements, the fair value of the Private Placement Vesting Warrants were valued using a model based on multiple stock price paths developed through the use of a Monte Carlo simulation that incorporates into the valuation the possibility that the market condition targets may not be satisfied. The Private Placement Warrants are collectively classified as a Level 3 measurement within the fair value hierarchy because these valuation models involve the use of unobservable inputs relating to the Company’s estimate of its expected stock volatility which was developed based on the historical volatility of a publicly traded set of peer companies. The expected volatility inputs utilized for the fair value measurements of the Private Placement Warrants as of April 30, 2023 and January 31, 2023 were 70.0% and 70.0%, respectively. Contingent Consideration for Acquisition of Business The Company recorded contingent consideration liabilities in connection with its acquisition of Salo Sciences, Inc. on January 3, 2023 (see Note 6 of the Company’s Consolidated Financial Statements included in the 2023 Form 10-K). The Company measures the fair value of the contingent consideration liabilities based on significant inputs not observable in the market, which caused them to be classified as a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability for the technical milestone payments is determined based on the present value of the probability-weighted payments for each of the milestones. The significant unobservable inputs used in the fair value measurement are management’s estimate of the probability to achieve the technical milestone criteria and the discount rate. The fair value of the contingent consideration liability for customer contract earnout payments is determined using a Monte Carlo simulation. The fair value estimate involves a simulation of future customer contract cash collections during the four Level 3 Disclosures The following is a rollforward of Level 3 liabilities measured at fair value for the three months ended April 30, 2023 and 2022: (in thousands) Private Placement Warrants Technical Milestone Contingent Consideration* Customer Contract Earnout Contingent Consideration* Fair value at end of year, January 31, 2022 $ 12,460 $ — $ — Change in fair value (1,068) — — Fair value at April 30, 2022 $ 11,392 $ — $ — Fair value at end of year, January 31, 2023 $ 9,701 $ 4,433 $ 3,597 Change in fair value (3,323) 5 (428) Fair value at April 30, 2023 $ 6,378 $ 4,438 $ 3,169 * As of April 30, 2023, the current portion of the contingent consideration liabilities is $0.5 million, which is included within accrued and other current liabilities. Changes in fair value of the contingent consideration liability for technical milestone payments are included within research and development expenses. Changes in fair value of the contingent consideration liability for customer contract earnout payments are included within sales and marketing expenses. Other

Balance Sheet Components

Balance Sheet Components	3 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Cash and Cash Equivalents, and Restricted Cash and Cash Equivalents Cash and cash equivalents include interest-bearing bank deposits, money market funds and other highly liquid investments with maturities of 90 days or less at the date of purchase. The Company had restricted cash and cash equivalents balances of $5.7 million and $6.2 million as of April 30, 2023 and January 31, 2023, respectively. The restricted cash and cash equivalents balances as of April 30, 2023 primarily consisted of $4.1 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases and $1.3 million of performance guarantees required for the Company’s foreign sales activities. The restricted cash and cash equivalents balances as of January 31, 2023 primarily consisted of $4.1 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases and $1.8 million of performance guarantees required for the Company’s foreign sales activities. A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of April 30, 2023 and January 31, 2023 is as follows: (in thousands) April 30, 2023 January 31, 2023 Cash and cash equivalents $ 140,763 $ 181,892 Restricted cash and cash equivalents, current 47 527 Restricted cash and cash equivalents, non-current 5,660 5,657 Total cash, cash equivalents, and restricted cash and cash equivalents $ 146,470 $ 188,076 The current restricted cash and cash equivalent balances as of April 30, 2023 and January 31, 2023 are included in prepaid expenses and other current assets. Short-term Investments Short-term investments consisted of the following as of April 30, 2023 and January 31, 2023: April 30, 2023 Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 73,417 $ 72 $ (134) $ 73,355 Commercial paper 9,426 9 — 9,435 Corporate bonds 140,878 166 (447) 140,597 U.S. government agency securities 12,077 6 (55) 12,028 Total short-term investments $ 235,798 $ 253 $ (636) $ 235,415 January 31, 2023 Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 59,255 $ 296 $ (118) $ 59,433 Commercial paper 19,744 105 — 19,849 Corporate bonds 139,644 34 (89) 139,589 U.S. government agency securities 8,063 — (66) 7,997 Total short-term investments $ 226,706 $ 435 $ (273) $ 226,868 The following table summarizes the contracted maturities of the Company’s short-term investments as of April 30, 2023 and January 31, 2023: April 30, 2023 January 31, 2023 (in thousands) Amortized Cost Fair Value Amortized Cost Fair Value Due in 1 year or less $ 157,755 $ 157,515 $ 124,068 $ 124,234 Due in 1-2 years 78,043 77,900 102,638 102,634 $ 235,798 $ 235,415 $ 226,706 $ 226,868 Property and Equipment, Net Property and equipment, net consists of the following: (in thousands) April 30, 2023 January 31, 2023 Satellites* $ 320,284 $ 307,720 Leasehold improvements 15,462 15,389 Ground stations and ground station equipment 17,209 15,113 Office furniture, equipment and fixtures 6,272 5,787 Computer equipment and purchased software 8,849 8,638 Total property and equipment, gross 368,076 352,647 Less: Accumulated depreciation (249,883) (244,556) Total property and equipment, net $ 118,193 $ 108,091 * Satellites include $22.9 million and $13.8 million of satellites in process and not placed into service as of April 30, 2023 and January 31, 2023, respectively. The Company’s long-lived assets by geographic region are as follows: (in thousands) April 30, 2023 January 31, 2023 United States $ 113,004 $ 103,366 Rest of World 5,189 4,725 Total property and equipment, net $ 118,193 $ 108,091 The Company concluded that satellites in service continue to be owned by the U.S. entity and accordingly are classified as U.S. assets in the table above. No single country other than the U.S. accounted for more than 10% of total property and equipment, net, as of April 30, 2023 and January 31, 2023. Total depreciation expense for the three months ended April 30, 2023 and 2022 was $8.7 million and $10.4 million, respectively, of which $8.2 million and $8.9 million, respectively, was depreciation expense specific to satellites. In April 2023, additional information specific to two high resolution satellites became available which indicated the useful lives of the two satellites will be less than originally estimated. The change in estimated useful lives for these satellites was accounted for prospectively beginning in April 2023 which resulted in a $0.4 million increase in depreciation expense for the three months ended April 30, 2023. The change in estimate is expected to result in a $5.0 million increase in depreciation expense for the fiscal year ended January 31, 2024. Capitalized Internal-Use Software Development Costs Capitalized internal-use software costs, net of accumulated amortization consists of the following: (in thousands) April 30, 2023 January 31, 2023 Capitalized internal-use software $ 40,480 $ 39,535 Less: Accumulated amortization (28,602) (28,118) Capitalized internal-use software, net $ 11,878 $ 11,417 Amortization expense for capitalized internal-use software for the three months ended April 30, 2023 and 2022 was $0.5 million and $0.5 million, respectively. Goodwill and Intangible Assets Goodwill and Intangible assets consist of the following: April 30, 2023 January 31, 2023 (in thousands) Gross Accumulated Foreign Net Gross Accumulated Foreign Net Developed technology $ 18,618 $ (9,244) $ (8) $ 9,366 $ 18,619 $ (8,871) $ (8) $ 9,740 Image library 12,637 (11,382) 246 1,501 12,384 (11,004) 231 1,611 Customer relationships 4,935 (2,990) 7 1,952 4,935 (2,788) 7 2,154 Trade names and other 4,551 (3,410) 39 1,180 4,551 (3,264) 39 1,326 Total intangible assets $ 40,741 $ (27,026) $ 284 $ 13,999 $ 40,489 $ (25,927) $ 269 $ 14,831 Goodwill $ 110,942 $ — $ 1,806 $ 112,748 $ 110,942 $ — $ 1,806 $ 112,748 Amortization expense for the three months ended April 30, 2023 and 2022 was $1.1 million and $0.7 million, respectively. Accrued and Other Current Liabilities Accrued liabilities and other current liabilities consist of the following: (in thousands) April 30, 2023 January 31, 2023 Deferred R&D service liability (see Note 7) $ 13,370 $ 19,959 Payroll and related expenses 4,609 8,518 Deferred hosting costs 4,772 4,694 Withholding taxes and other taxes payable 2,642 2,272 Other accruals 9,039 10,579 Total accrued and other current liabilities $ 34,432 $ 46,022

Leases

Leases	3 Months Ended
	Apr. 30, 2023
Leases [Abstract]
Leases	Leases The Company’s leasing activities primarily consist of real estate leases for its operations, including office space, and certain ground station service agreements that convey the right to control the use of specified equipment and facilities. The Company assesses whether each lease is an operating or finance lease at the lease commencement date. As of April 30, 2023, the Company has no finance leases. Operating lease costs were $2.0 million and $1.5 million for the three months ended April 30, 2023 and 2022, respectively. Variable lease expenses, short-term lease expenses and sublease income were immaterial for the three months ended April 30, 2023 and 2022. Operating cash flows from operating leases were $1.1 million and $2.0 million for the three months ended April 30, 2023 and 2022, respectively. Right of use assets obtained in exchange for operating lease liabilities were $4.8 million for the three months ended April 30, 2023. There were no right of use assets obtained in exchange for operating lease liabilities for the three months ended April 30, 2022. Maturities of operating lease liabilities as of April 30, 2023 were as follows: (in thousands) Remainder of Fiscal Year 2024 $ 5,965 2025 8,607 2026 8,371 2027 5,232 2028 1,206 Thereafter 857 Total lease payments $ 30,238 Less: Imputed interest (4,006) Total lease liabilities $ 26,232 Weighted average remaining lease term (years) 3.8 Weighted average discount rate 7.9 %

Research and Development Arrang

Research and Development Arrangements	3 Months Ended
	Apr. 30, 2023
Research and Development [Abstract]
Research and Development Arrangements	Research and Development Arrangements Research and Development Services Agreement In December 2020, the Company entered into a development services agreement whereby the Company agreed to provide the technical knowledge and services to design and develop certain prototype satellites and deliver and test early data collected (the “ R&D Services Agreement ”). The R&D Services Agreement, including subsequent amendments to such agreement, provides for funding of $45.8 million to be paid to the Company as specified milestones are achieved over a three year period. The R&D Services Agreement is unrelated to the Company’s ordinary business activities. The Company has discretion in managing the activities under the R&D Services Agreement and retains all developed intellectual property. The Company has no obligation to repay any of the funds received regardless of the outcome of the development work; therefore, the arrangement is accounted for as funded research and development pursuant to ASC 730-20, Research and Development . As ASC 730-20 does not indicate the accounting model for research and development services, the Company determined the total transaction price is recognized over the agreement term as a reduction of research and development expenses based on a cost incurred method. During the three months ended April 30, 2023 and 2022, the Company recognized $4.0 million and $2.8 million of funding and incurred $4.0 million and $2.8 million of research and development expenses, respectively, in connection with the R&D Services Agreement. As of April 30, 2023 and January 31, 2023, the Company had received total funding of $36.9 million and $36.3 million, respectively, under the R&D Services Agreement. NASA Communication Services Project In connection with its Communication Services Project (“CSP”), the National Aeronautics and Space Administration (“NASA”) selected certain satellite communications providers that NASA will fund to develop and demonstrate near-Earth space communication services that may support future NASA missions using commercial technology. In June 2022 and August 2022, the Company entered into separate agreements with two of the satellite communications providers selected by NASA whereby the Company agreed to participate in the NASA CSP as a subcontractor. The agreements provide for the Company to receive aggregate funding of $40.5 million to be paid as milestones are completed. The Company determined that the agreements are in the scope of ASC 912-730, Contractors –Federal Government – Research and Development (“ASC 912-730”). In accordance with ASC 912-730, funding is recognized over the term of each agreement as a reduction of research and development expenses based on a cost incurred method.

Commitment and Contingencies

Commitment and Contingencies	3 Months Ended
	Apr. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Launch Services The Company has purchase commitments for future satellite launch services to be performed by third-parties subsequent to April 30, 2023. Future purchase commitments under noncancelable launch service contracts as of April 30, 2023 are as follows: (in thousands) Remainder of Fiscal Year 2024 $ 475 Total purchase commitments $ 475 Other The Company has minimum purchase commitments for hosting services from Google through January 31, 2028 (see Note 10). Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of April 30, 2023 is as follows: (in thousands) Remainder of Fiscal Year 2024 $ 19,802 2025 30,120 2026 31,190 2027 32,725 2028 33,427 Total purchase commitments $ 147,264 Contingencies The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims, individually or in the aggregate, that are expected to have a material adverse impact on its condensed consolidated financial statements as of each reporting period. From time to time however, the Company may have certain contingent liabilities that arise in the ordinary course of business activities including those arising from disputes and claims and events arising from revenue contracts entered into by the Company. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. Indemnification The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent, or other intellectual property infringement claim by any third-party with respect to its technology. The term of these indemnification agreements is generally perpetual after the execution of the agreement. The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. In the event that one or more of these matters were to result in a claim against the Company, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on the Company’s future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify them against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. To date, we have not incurred any material costs, and have not accrued any liabilities in the consolidated financial statements as a result of these provisions.

Warrants

Warrants	3 Months Ended
	Apr. 30, 2023
Warrants [Abstract]
Warrants	Warrants Public and Private Placement Warrants In connection with dMY IV’s initial public offering, which occurred on March 9, 2021, dMY IV issued 34,500,000 units, each unit consisting of one share of Class A common stock of dMY IV and one-fifth of one redeemable warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (the “Public Warrants”). Simultaneously with the closing of its initial public offering, dMY IV completed the private sale of 5,933,333 warrants to dMY Sponsor IV, LLC (the “dMY Sponsor”) at a purchase price of $1.50 per warrant (the “Private Placement Warrants”). Each Private Placement Warrant is exercisable for one share of Class A common stock at $11.50 per share. Additionally, pursuant to a lock-up agreement entered into with the dMY Sponsor in connection with the Business Combination, 2,966,667 of the Private Placement Warrants are subject to vesting conditions (the “Private Placement Vesting Warrants”). The Private Placement Vesting Warrants vest in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. Any right to Private Placement Vesting Warrants that remains unvested on the first business day after five years from the closing of the Business Combination will be forfeited without any further consideration. As of April 30, 2023 and January 31, 2023, there were 6,899,982 Public Warrants and 5,933,333 Private Placement Warrants, including 2,966,667 Private Placement Vesting Warrants, outstanding. Warrants to Purchase Class A Common Stock In addition to the Public and Private Placement Warrants, there were 1,065,594 warrants to purchase shares of Class A common stock with a weighted average exercise price of $9.384 which were outstanding and exercisable as of April 30, 2023 and January 31, 2023. As of April 30, 2023, the outstanding warrants have a weighted average remaining term of 6.9 years.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Apr. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions As of April 30, 2023 and January 31, 2023, Google owned greater than 10% of the Company’s common shares through its total investment of 31,942,641 shares of Class A common stock. In April 2017, the Company and Google entered into a five year content license agreement pursuant to which the Company licensed content to Google. In April 2022, the agreement automatically renewed for a period of one year and, in April 2023, the agreement expired. As of January 31, 2023, the deferred revenue balance associated with the content license agreement was $0.3 million. For the three months ended April 30, 2023 and 2022, the Company recognized revenue of $0.3 million and $3.0 million, respectively, related to the content license agreement. In ad dition, the Company purchases hosting and other services from Google, of which $15.4 million and $13.4 million is deferred as of April 30, 2023 and January 31, 2023 , respectively. The Company recorded hosting expense of $6.4 million and $5.5 million during the three months ended April 30, 2023 and 2022 , respectively. As of April 30, 2023 and January 31, 2023 , the Company’s accounts payable and accrued liabilities balance included $2.6 million and $2.3 million related to hosting and other services provided by Google, respectively.

Stock-based Compensation

Stock-based Compensation	3 Months Ended
	Apr. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation Prior to the Business Combination, the Company issued equity awards under the Planet Labs Inc. Amended and Restated 2011 Stock Incentive Plan (the “ Legacy Incentive Plan ”). In connection with the Business Combination, the Company adopted the Planet Labs PBC 2021 Incentive Award Plan (the “ Incentive Plan ”). No further awards will be granted under the Legacy Incentive Plan. Directors, employees and consultants are eligible to receive awards under the Incentive Plan; however, ISOs may only be granted to employees. The Company's equity incentive plans are described in Note 15, Stock-based Compensation , in the Notes to the Consolidated Financial Statements in the 2023 Form 10-K. Stock-Based Compensation The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows: Three Months Ended April 30, (in thousands) 2023 2022 Cost of revenue $ 917 $ 1,319 Research and development 6,585 8,666 Sales and marketing 3,080 3,637 General and administrative 5,401 6,637 Total expense 15,983 20,259 Capitalized to internal-use software development costs and property and equipment (627) (437) Total stock-based compensation expense $ 15,356 $ 19,822 Stock Options A summary of stock option activity is as follows: Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Term (Years) Aggregate Intrinsic Value (in thousands) Balances at January 31, 2023 33,721,774 $ 5.08 6.3 Exercised (1,018,385) $ 3.24 Granted — $ — Forfeited (551,142) $ 8.18 Balances at April 30, 2023 32,152,247 $ 5.09 6.0 $ 13,203 Vested and exercisable at April 30, 2023 25,077,219 $ 4.32 5.5 $ 13,088 As of April 30, 2023, total unrecognized compensation cost related to stock options was $26.3 million which is expected to be recognized over a period of 2.0 years . Restricted Stock Units A summary of Restricted Stock Unit (“RSU”) activity is as follows: Number of RSUs Weighted Average Grant Date Fair Value Balances at January 31, 2023 16,972,601 $ 5.90 Vested (1,278,161) $ 5.87 Granted 15,709,449 $ 3.98 Forfeited (308,214) $ 5.15 Balances at April 30, 2023 31,095,675 $ 4.94 During the three months ended April 30, 2023, the Company granted 15,709,449 RSUs, which generally vest over four years, subject to the recipient’s continued service through each applicable vesting date. Stock-based compensation expense recognized for RSUs during the three months ended April 30, 2023 and 2022 was $9.4 million and $8.5 million, respectively. As of April 30, 2023, total unrecognized compensation cost related to RSUs was $127.0 million. These costs are expected to be recognized over a period of approximately 3.3 years . Performance Vesting Restricted Stock Units On April 24, 2023, the Company granted 265,825 performance vesting restricted stock units (“PSUs”) to certain members of the Company’s senior management. A portion of the PSUs are subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the first half of the fiscal year ended January 31, 2024 and the remaining portion is subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the entire fiscal year ended January 31, 2024. Vesting is also subject to continued service through the applicable vesting dates and the actual number of PSUs that may vest ranges from 0% to 125% of the PSUs granted based on achievement of the targets. Stock-based compensation expense recognized for PSUs during the three months ended April 30, 2023 was immaterial. As of April 30, 2023, total unrecognized compensation cost related to PSUs was $1.0 million. These costs are expected to be recognized over a period of approximately 0.9 years. Early Exercises of Stock Options The Legacy Incentive Plan provided for the early exercise of stock options for certain individuals as determined by the Company’s board of directors. Shares of common stock issued upon early exercises of unvested options are not deemed, for accounting purposes, to be issued until those shares vest according to their respective vesting schedules and accordingly, the consideration received for early exercises is initially recorded as a liability and reclassified to common stock and additional paid-in capital as the underlying awards vest. As of April 30, 2023, the Company had a $11.7 million liability recorded for the early exercise of unvested stock options, and the related number of unvested shares subject to repurchase was 1,194,830. Earn-out Shares Pursuant to the Merger Agreement, Former Planet equity award holders have the right to receive Earn-out Shares that are contingently issuable in shares of Class A common stock. The Earn-out Shares may be earned in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. No Earn-out Shares vested during the three months ended April 30, 2023 and 2022. As of April 30, 2023, there were 4,108,375 Earn-out Shares outstanding relating to Former Planet equity award holders. During the three months ended April 30, 2023 and 2022, the Company recognized $2.3 million and $7.1 million of stock-based compensation expense related to the Earn-out Shares, respectively. As of April 30, 2023, total unrecognized compensation cost related to the Earn-out Shares was $2.8 million, which is expected to be recognized over a period of approximately 0.5 years . Other Stock-based Compensation In connection with the acquisition of VanderSat B.V. (“VanderSat”) on December 13, 2021, the Company issued 543,391 shares of Class A common stock to an employee and former owner of VanderSat which are accounted for as stock-based compensation because the shares are subject to forfeiture based on post-acquisition time-based service vesting. The shares vest in quarterly increments over two years commencing on December 13, 2021. During three months ended April 30, 2023 and 2022, the Company recognized $0.6 million and $0.6 million of stock-based compensation expense related to these shares, respectively. As of April 30, 2023, unrecognized compensation cost related to these shares was $1.6 million. These costs are expected to be recognized over a period of approximately 0.7 years.

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company recorded income tax expense of $0.3 million for both the three month periods ended April 30, 2023 and 2022. For the three months ended April 30, 2023 and 2022, the income tax expense was primarily driven by the current tax on foreign earnings. The effective tax rates for the three months ended April 30, 2023 and 2022 differed from the federal statutory tax rate primarily due to the valuation allowance on the majority of the Company’s U.S. and foreign deferred tax assets and foreign rate differences. The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. Gross unrecognized tax benefits were $7.2 million and $6.9 million as of April 30, 2023 and January 31, 2023, respectively. The gross unrecognized tax benefits, if recognized, would not affect the effective tax rate due to the valuation allowance against the deferred tax assets. The Company determined that no accrual for interest and penalties was required as of April 30, 2023 and January 31, 2023 and no such expenses were incurred in the periods presented. The Company does not anticipate the total amounts of unrecognized tax benefits to significantly increase or decrease in the next twelve months. The Company files U.S. federal, various state and foreign income tax returns. The Company is not currently under audit by any taxing authorities. All tax years remain open to examination by taxing jurisdictions to which the Company is subject.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	3 Months Ended
	Apr. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The Company computes net loss per share of the Class A common stock and Class B common stock using the two-class method required for participating securities. Basic and diluted net loss per share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts): Three Months Ended April 30, 2023 2022 Numerator: Net loss attributable to common stockholders $ (34,444) $ (44,360) Denominator: Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders 272,347,977 264,088,997 Basic and diluted net loss per share attributable to common stockholders $ (0.13) $ (0.17) Basic and diluted net loss per share was the same for each period presented as the inclusion of all potential Class A common stock and Class B common stock outstanding would have been anti-dilutive. The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: Three Months Ended April 30, 2023 2022 Warrants to purchase Class A common stock 1,065,594 1,065,594 Common stock options 32,152,247 38,924,582 Restricted Stock Units 31,095,675 13,949,577 Earn-out Shares 25,567,385 26,172,277 dMY Sponsor Earn-out Shares 862,500 862,500 Public Warrants 6,899,982 6,899,982 Private Placement Warrants 5,933,333 5,933,333 Early exercised common stock options, subject to future vesting 1,194,830 1,562,476 Shares issued in connection with acquisition, subject to future vesting 203,771 475,467 104,975,317 95,845,788

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three months ended April 30, 2023 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2024 or any other future period. The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, allowances for credit losses for available-for-sale debt securities and accounts receivable, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, assumptions used to measure stock-based compensation, the fair value of warrants, the fair value of assets acquired, and liabilities assumed from business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies. These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent uncertainties in making estimates, actual results could differ from those estimates and such differences may be material to the unaudited condensed consolidated financial statements. Due to the COVID-19 Coronavirus pandemic (“COVID-19” or “COVID-19 pandemic”), and current events involving Russia and Ukraine, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur, and additional information is obtained.
Segments	Segments Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.
Concentration of Credit Risk and Other Risks and Uncertainties	Concentration of Credit Risk and Other Risks and Uncertainties Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with or held by financial institutions in the U.S., Canada, Germany, the Netherlands and Singapore. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits. The maximum amount of loss at April 30, 2023 that the Company would incur if parties to cash, cash equivalents, and short-term investments failed completely to perform according to the terms of the contracts is $374.9 million. Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. As of April 30, 2023, one customer accounted for 17% of accounts receivable. As of January 31, 2023, one customer accounted for 15% of accounts receivable. For the three months ended April 30, 2023, one customer accounted for 21% of revenue. For the three months ended April 30, 2022, two customers accounted for 11% and 10% of revenue. The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations.
Recently Adopted Accounting Pronouncements

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule Of Disaggregation of Revenue	The following table disaggregates revenue by major geographic region: Three Months Ended April 30, (in thousands) 2023 2022 United States $ 23,127 $ 18,752 Rest of World 29,576 21,375 Total revenue $ 52,703 $ 40,127
Schedule of Deferred Commissions	As of April 30, 2023 and January 31, 2023, deferred commissions consisted of the following: (in thousands) April 30, 2023 January 31, 2023 Deferred commission, current $ 2,310 $ 2,405 Deferred commission, non-current 1,942 2,206 Total deferred commission $ 4,252 $ 4,611

Fair Value of Financial Asset_2

Fair Value of Financial Assets and Liabilities (Tables)	3 Months Ended
	Apr. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability. April 30, 2023 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds 90,136 — — U.S. Treasury securities 990 — — Restricted cash equivalents: money market funds 5,486 — — Short-term investments: U.S. Treasury securities 73,355 — — Commercial paper — 9,435 — Corporate bonds — 140,597 — U.S. government agency securities — 12,028 — Total assets $ 169,967 $ 162,060 $ — Liabilities Public Warrants 4,347 — — Private Placement Warrants — — 6,378 Contingent consideration for acquisition of business — — 7,607 Total liabilities $ 4,347 $ — $ 13,985 January 31, 2023 (in thousands) Level 1 Level 2 Level 3 Assets Cash equivalents: Money market funds 72,382 — — Commercial paper — 999 — Restricted cash equivalents: money market funds 5,486 — — Short-term investments: U.S. Treasury securities 59,433 — — Commercial paper — 19,849 — Corporate bonds — 139,589 — U.S. government agency securities — 7,997 — Total assets $ 137,301 $ 168,434 $ — Liabilities Public Warrants 6,969 — — Private Placement Warrants — — 9,701 Contingent consideration for acquisition of business — — 8,030 Total liabilities $ 6,969 $ — $ 17,731
Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following is a rollforward of Level 3 liabilities measured at fair value for the three months ended April 30, 2023 and 2022: (in thousands) Private Placement Warrants Technical Milestone Contingent Consideration* Customer Contract Earnout Contingent Consideration* Fair value at end of year, January 31, 2022 $ 12,460 $ — $ — Change in fair value (1,068) — — Fair value at April 30, 2022 $ 11,392 $ — $ — Fair value at end of year, January 31, 2023 $ 9,701 $ 4,433 $ 3,597 Change in fair value (3,323) 5 (428) Fair value at April 30, 2023 $ 6,378 $ 4,438 $ 3,169 * As of April 30, 2023, the current portion of the contingent consideration liabilities is $0.5 million, which is included within accrued and other current liabilities. Changes in fair value of the contingent consideration liability for technical milestone payments are included within research and development expenses. Changes in fair value of the contingent consideration liability for customer contract earnout payments are included within sales and marketing expenses.

Balance Sheet Components (Table

Balance Sheet Components (Tables)	3 Months Ended
	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Cash and Cash Equivalents	A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of April 30, 2023 and January 31, 2023 is as follows: (in thousands) April 30, 2023 January 31, 2023 Cash and cash equivalents $ 140,763 $ 181,892 Restricted cash and cash equivalents, current 47 527 Restricted cash and cash equivalents, non-current 5,660 5,657 Total cash, cash equivalents, and restricted cash and cash equivalents $ 146,470 $ 188,076
Debt Securities, Available-for-Sale	Short-term investments consisted of the following as of April 30, 2023 and January 31, 2023: April 30, 2023 Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 73,417 $ 72 $ (134) $ 73,355 Commercial paper 9,426 9 — 9,435 Corporate bonds 140,878 166 (447) 140,597 U.S. government agency securities 12,077 6 (55) 12,028 Total short-term investments $ 235,798 $ 253 $ (636) $ 235,415 January 31, 2023 Gross Unrealized (in thousands) Cost or Amortized Cost Gains Losses Fair Value U.S Treasury securities $ 59,255 $ 296 $ (118) $ 59,433 Commercial paper 19,744 105 — 19,849 Corporate bonds 139,644 34 (89) 139,589 U.S. government agency securities 8,063 — (66) 7,997 Total short-term investments $ 226,706 $ 435 $ (273) $ 226,868
Investments Classified by Contractual Maturity Date	The following table summarizes the contracted maturities of the Company’s short-term investments as of April 30, 2023 and January 31, 2023: April 30, 2023 January 31, 2023 (in thousands) Amortized Cost Fair Value Amortized Cost Fair Value Due in 1 year or less $ 157,755 $ 157,515 $ 124,068 $ 124,234 Due in 1-2 years 78,043 77,900 102,638 102,634 $ 235,798 $ 235,415 $ 226,706 $ 226,868
Schedule of Property and Equipment	Property and equipment, net consists of the following: (in thousands) April 30, 2023 January 31, 2023 Satellites* $ 320,284 $ 307,720 Leasehold improvements 15,462 15,389 Ground stations and ground station equipment 17,209 15,113 Office furniture, equipment and fixtures 6,272 5,787 Computer equipment and purchased software 8,849 8,638 Total property and equipment, gross 368,076 352,647 Less: Accumulated depreciation (249,883) (244,556) Total property and equipment, net $ 118,193 $ 108,091 * Satellites include $22.9 million and $13.8 million of satellites in process and not placed into service as of April 30, 2023 and January 31, 2023, respectively.
Schedule of Long-lived Assets by Geographic Areas	The Company’s long-lived assets by geographic region are as follows: (in thousands) April 30, 2023 January 31, 2023 United States $ 113,004 $ 103,366 Rest of World 5,189 4,725 Total property and equipment, net $ 118,193 $ 108,091
Schedule of Capitalized Computer Software	Capitalized internal-use software costs, net of accumulated amortization consists of the following: (in thousands) April 30, 2023 January 31, 2023 Capitalized internal-use software $ 40,480 $ 39,535 Less: Accumulated amortization (28,602) (28,118) Capitalized internal-use software, net $ 11,878 $ 11,417
Schedule of Intangible Assets And Goodwill	Goodwill and Intangible assets consist of the following: April 30, 2023 January 31, 2023 (in thousands) Gross Accumulated Foreign Net Gross Accumulated Foreign Net Developed technology $ 18,618 $ (9,244) $ (8) $ 9,366 $ 18,619 $ (8,871) $ (8) $ 9,740 Image library 12,637 (11,382) 246 1,501 12,384 (11,004) 231 1,611 Customer relationships 4,935 (2,990) 7 1,952 4,935 (2,788) 7 2,154 Trade names and other 4,551 (3,410) 39 1,180 4,551 (3,264) 39 1,326 Total intangible assets $ 40,741 $ (27,026) $ 284 $ 13,999 $ 40,489 $ (25,927) $ 269 $ 14,831 Goodwill $ 110,942 $ — $ 1,806 $ 112,748 $ 110,942 $ — $ 1,806 $ 112,748
Schedule of Accrued Liabilities and Other Current Liabilities	Accrued liabilities and other current liabilities consist of the following: (in thousands) April 30, 2023 January 31, 2023 Deferred R&D service liability (see Note 7) $ 13,370 $ 19,959 Payroll and related expenses 4,609 8,518 Deferred hosting costs 4,772 4,694 Withholding taxes and other taxes payable 2,642 2,272 Other accruals 9,039 10,579 Total accrued and other current liabilities $ 34,432 $ 46,022

Leases (Tables)

Leases (Tables)	3 Months Ended
	Apr. 30, 2023
Leases [Abstract]
Schedule of Maturities of Operating Lease Liabilities	Maturities of operating lease liabilities as of April 30, 2023 were as follows: (in thousands) Remainder of Fiscal Year 2024 $ 5,965 2025 8,607 2026 8,371 2027 5,232 2028 1,206 Thereafter 857 Total lease payments $ 30,238 Less: Imputed interest (4,006) Total lease liabilities $ 26,232 Weighted average remaining lease term (years) 3.8 Weighted average discount rate 7.9 %

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	3 Months Ended
	Apr. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Purchase Commitments	Future purchase commitments under noncancelable launch service contracts as of April 30, 2023 are as follows: (in thousands) Remainder of Fiscal Year 2024 $ 475 Total purchase commitments $ 475
Schedule of Other Commitments	Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of April 30, 2023 is as follows: (in thousands) Remainder of Fiscal Year 2024 $ 19,802 2025 30,120 2026 31,190 2027 32,725 2028 33,427 Total purchase commitments $ 147,264

Stock-based Compensation (Table

Stock-based Compensation (Tables)	3 Months Ended
	Apr. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-Based Compensation Expense	The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows: Three Months Ended April 30, (in thousands) 2023 2022 Cost of revenue $ 917 $ 1,319 Research and development 6,585 8,666 Sales and marketing 3,080 3,637 General and administrative 5,401 6,637 Total expense 15,983 20,259 Capitalized to internal-use software development costs and property and equipment (627) (437) Total stock-based compensation expense $ 15,356 $ 19,822
Summary of Stock Option Activity	A summary of stock option activity is as follows: Options Outstanding Number of Options Weighted Average Exercise Price Weighted Average Remaining Term (Years) Aggregate Intrinsic Value (in thousands) Balances at January 31, 2023 33,721,774 $ 5.08 6.3 Exercised (1,018,385) $ 3.24 Granted — $ — Forfeited (551,142) $ 8.18 Balances at April 30, 2023 32,152,247 $ 5.09 6.0 $ 13,203 Vested and exercisable at April 30, 2023 25,077,219 $ 4.32 5.5 $ 13,088
Summary of Restricted Stock Unit ("RSU") Activity	A summary of Restricted Stock Unit (“RSU”) activity is as follows: Number of RSUs Weighted Average Grant Date Fair Value Balances at January 31, 2023 16,972,601 $ 5.90 Vested (1,278,161) $ 5.87 Granted 15,709,449 $ 3.98 Forfeited (308,214) $ 5.15 Balances at April 30, 2023 31,095,675 $ 4.94

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	3 Months Ended
	Apr. 30, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts): Three Months Ended April 30, 2023 2022 Numerator: Net loss attributable to common stockholders $ (34,444) $ (44,360) Denominator: Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders 272,347,977 264,088,997 Basic and diluted net loss per share attributable to common stockholders $ (0.13) $ (0.17)
Schedule of Antidilutive Securities	The following table presents the potential common stock outstanding that was excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: Three Months Ended April 30, 2023 2022 Warrants to purchase Class A common stock 1,065,594 1,065,594 Common stock options 32,152,247 38,924,582 Restricted Stock Units 31,095,675 13,949,577 Earn-out Shares 25,567,385 26,172,277 dMY Sponsor Earn-out Shares 862,500 862,500 Public Warrants 6,899,982 6,899,982 Private Placement Warrants 5,933,333 5,933,333 Early exercised common stock options, subject to future vesting 1,194,830 1,562,476 Shares issued in connection with acquisition, subject to future vesting 203,771 475,467 104,975,317 95,845,788

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Basis of Presentation and Liquidity (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Accounting Policies [Abstract]
Cash and cash equivalents	$ 140,763	$ 181,892
Short-term investments	$ 235,415	$ 226,868

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Segments (Details)	3 Months Ended
	Apr. 30, 2023 segment
Accounting Policies [Abstract]
Number of operating segments	1
Number of reportable segments	1

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk and Other Risks and Uncertainties (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Concentration Risk [Line Items]
Concentration risk, credit risk, maximum exposure	$ 374.9
Customer Concentration Risk | Accounts Receivable | Customer 1
Concentration Risk [Line Items]
Concentration risk	17%	11%	15%
Customer Concentration Risk | Accounts Receivable | Customer 2
Concentration Risk [Line Items]
Concentration risk		10%
Customer Concentration Risk | Revenue Benchmark | Customer 1
Concentration Risk [Line Items]
Concentration risk	21%

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Disaggregation of Revenue [Line Items]
Deferred revenue, revenue recognized	$ 25.1	$ 22.6
Remaining performance obligation, amount	138
Deferred revenue	47.1
Non-cancelable contract revenue	90.9
Deferred commission expense	0.2	0.5
Amortization of deferred commission	$ 0.6	$ 0.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-05-01 | Minimum
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	80%
Remaining performance obligation, expected timing of satisfaction	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-05-01 | Maximum
Disaggregation of Revenue [Line Items]
Remaining performance obligation, percentage	99%
Remaining performance obligation, expected timing of satisfaction	24 months

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands		3 Months Ended
		Apr. 30, 2023	Apr. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	[1]	$ 52,703	$ 40,127
United States
Disaggregation of Revenue [Line Items]
Revenue		23,127	18,752
Rest of World
Disaggregation of Revenue [Line Items]
Revenue		$ 29,576	$ 21,375
[1]Balance includes related-party transactions entered into with Google. See Note 10.

Revenue - Schedule of Deferred

Revenue - Schedule of Deferred Commissions (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred commission, current	$ 2,310	$ 2,405
Deferred commission, non-current	1,942	2,206
Total deferred commission	$ 4,252	$ 4,611

Fair Value of Financial Asset_3

Fair Value of Financial Assets and Liabilities - Schedule of Fair Value by Balance Sheet Location (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Assets
Short-term investments	$ 235,415	$ 226,868
Liabilities
Warrants	10,725	16,670
U.S. Treasury securities
Assets
Short-term investments	73,355	59,433
Commercial paper
Assets
Short-term investments	9,435	19,849
Corporate bonds
Assets
Short-term investments	140,597	139,589
U.S. government agency securities
Assets
Short-term investments	12,028	7,997
Fair Value, Recurring | Level 1
Assets
Total assets	169,967	137,301
Liabilities
Total liabilities	4,347	6,969
Fair Value, Recurring | Level 1 | Public Warrants
Liabilities
Warrants	4,347	6,969
Fair Value, Recurring | Level 1 | Private Placement Warrants
Liabilities
Warrants	0	0
Fair Value, Recurring | Level 1 | Contingent consideration for acquisition of business
Liabilities
Warrants	0	0
Fair Value, Recurring | Level 1 | U.S. Treasury securities
Assets
Short-term investments	73,355	59,433
Fair Value, Recurring | Level 1 | Commercial paper
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 1 | Corporate bonds
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 1 | U.S. government agency securities
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 1 | Money market funds
Assets
Cash equivalents:	90,136	72,382
Restricted cash equivalents: money market funds	5,486	5,486
Fair Value, Recurring | Level 1 | U.S. Treasury securities
Assets
Cash equivalents:	990
Fair Value, Recurring | Level 1 | Commercial paper
Assets
Cash equivalents:		0
Fair Value, Recurring | Level 2
Assets
Total assets	162,060	168,434
Liabilities
Total liabilities	0	0
Fair Value, Recurring | Level 2 | Public Warrants
Liabilities
Warrants	0	0
Fair Value, Recurring | Level 2 | Private Placement Warrants
Liabilities
Warrants	0	0
Fair Value, Recurring | Level 2 | Contingent consideration for acquisition of business
Liabilities
Warrants	0	0
Fair Value, Recurring | Level 2 | U.S. Treasury securities
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 2 | Commercial paper
Assets
Short-term investments	9,435	19,849
Fair Value, Recurring | Level 2 | Corporate bonds
Assets
Short-term investments	140,597	139,589
Fair Value, Recurring | Level 2 | U.S. government agency securities
Assets
Short-term investments	12,028	7,997
Fair Value, Recurring | Level 2 | Money market funds
Assets
Cash equivalents:	0	0
Restricted cash equivalents: money market funds	0	0
Fair Value, Recurring | Level 2 | U.S. Treasury securities
Assets
Cash equivalents:	0
Fair Value, Recurring | Level 2 | Commercial paper
Assets
Cash equivalents:		999
Fair Value, Recurring | Level 3
Assets
Total assets	0	0
Liabilities
Total liabilities	13,985	17,731
Fair Value, Recurring | Level 3 | Public Warrants
Liabilities
Warrants	0	0
Fair Value, Recurring | Level 3 | Private Placement Warrants
Liabilities
Warrants	6,378	9,701
Fair Value, Recurring | Level 3 | Contingent consideration for acquisition of business
Liabilities
Warrants	7,607	8,030
Fair Value, Recurring | Level 3 | U.S. Treasury securities
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3 | Commercial paper
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3 | Corporate bonds
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3 | U.S. government agency securities
Assets
Short-term investments	0	0
Fair Value, Recurring | Level 3 | Money market funds
Assets
Cash equivalents:	0	0
Restricted cash equivalents: money market funds	0	0
Fair Value, Recurring | Level 3 | U.S. Treasury securities
Assets
Cash equivalents:	$ 0
Fair Value, Recurring | Level 3 | Commercial paper
Assets
Cash equivalents:		$ 0

Fair Value of Financial Asset_4

Fair Value of Financial Assets and Liabilities - Additional Information (Details) $ / shares in Units, $ in Millions		3 Months Ended
	Mar. 09, 2021 $ / shares shares	Apr. 30, 2022	Apr. 30, 2023 USD ($) shares	Jan. 31, 2023 shares	Dec. 07, 2021 shares
Salo Sciences
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Performance period		4 years
Salo Sciences | Accrued and Other Current Liabilities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Current portion of contingent consideration | $			$ 0.5
dMY IV, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity units issued (in shares) | shares	34,500,000
Redeemable Warrant | dMY IV, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant exercise price (in dollars per share) | $ / shares	$ 10
Private Placement Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant outstanding (in shares) | shares			5,933,333	5,933,333	2,966,667
Private Placement Warrants | dMY IV, LLC
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrant exercise price (in dollars per share) | $ / shares	$ 11.50
Warrant outstanding (in shares) | shares	5,933,333
Sale of stock, price per share (in dollars per share) | $ / shares	$ 1.50
Private Placement Warrants | Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants, measurement input			0.00700	0.00700

Fair Value of Financial Asset_5

Fair Value of Financial Assets and Liabilities - Schedule of Liabilities with Unobservable Inputs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Salo Sciences | Technical Milestone Contingent Consideration*
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 4,433	$ 0
Change in fair value	5	0
Ending balance	4,438	0
Salo Sciences | Customer Contract Earnout Contingent Consideration*
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	3,597	0
Change in fair value	(428)	0
Ending balance	3,169	0
Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	9,701	12,460
Change in fair value	(3,323)	(1,068)
Ending balance	$ 6,378	$ 11,392

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) $ in Millions	1 Months Ended		3 Months Ended		12 Months Ended
	Apr. 30, 2023 USD ($) satellite	Aug. 31, 2022 satellite	Apr. 30, 2023 USD ($)	Apr. 30, 2022 USD ($)	Jan. 31, 2024 USD ($)	Jan. 31, 2023 USD ($)
Property, Plant and Equipment [Line Items]
Restricted cash	$ 5.7		$ 5.7			$ 6.2
Depreciation			8.7	$ 10.4
Capitalized computer software, amortization			0.5	0.5
Amortization of intangible assets			1.1	0.7
Satellites
Property, Plant and Equipment [Line Items]
Depreciation			8.2	$ 8.9
Number of satellites | satellite	2	2
Satellites | Service Life
Property, Plant and Equipment [Line Items]
Depreciation			0.4
Satellites | Forecast | Service Life
Property, Plant and Equipment [Line Items]
Depreciation					$ 5
Performance Guarantees
Property, Plant and Equipment [Line Items]
Restricted cash	$ 1.3		1.3			1.8
Money market funds
Property, Plant and Equipment [Line Items]
Restricted cash	$ 4.1		$ 4.1			$ 4.1

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Cash and Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023	Apr. 30, 2022	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and cash equivalents	$ 140,763	$ 181,892
Restricted cash and cash equivalents, current	47	527
Restricted cash and cash equivalents, non-current	5,660	5,657
Total cash, cash equivalents, and restricted cash and cash equivalents	$ 146,470	$ 188,076	$ 490,531	$ 496,814

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Short-term Investments (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Short-Term Debt [Line Items]
Cost or Amortized Cost	$ 235,798	$ 226,706
Gains	253	435
Losses	(636)	(273)
Short-term investments	235,415	226,868
U.S. Treasury securities
Short-Term Debt [Line Items]
Cost or Amortized Cost	73,417	59,255
Gains	72	296
Losses	(134)	(118)
Short-term investments	73,355	59,433
Commercial paper
Short-Term Debt [Line Items]
Cost or Amortized Cost	9,426	19,744
Gains	9	105
Losses	0	0
Short-term investments	9,435	19,849
Corporate bonds
Short-Term Debt [Line Items]
Cost or Amortized Cost	140,878	139,644
Gains	166	34
Losses	(447)	(89)
Short-term investments	140,597	139,589
U.S. government agency securities
Short-Term Debt [Line Items]
Cost or Amortized Cost	12,077	8,063
Gains	6	0
Losses	(55)	(66)
Short-term investments	$ 12,028	$ 7,997

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Contracted Maturities (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Amortized Cost
Due in 1 year or less	$ 157,755	$ 124,068
Due in 1-2 years	78,043	102,638
Cost or Amortized Cost	235,798	226,706
Fair Value
Due in 1 year or less	157,515	124,234
Due in 1-2 years	77,900	102,634
Short-term investments	$ 235,415	$ 226,868

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 368,076	$ 352,647
Less: Accumulated depreciation	(249,883)	(244,556)
Property and equipment, net	118,193	108,091
United States
Property, Plant and Equipment [Line Items]
Property and equipment, net	113,004	103,366
Rest of World
Property, Plant and Equipment [Line Items]
Property and equipment, net	5,189	4,725
Satellites
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	320,284	307,720
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	15,462	15,389
Ground stations and ground station equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	17,209	15,113
Office furniture, equipment and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	6,272	5,787
Computer equipment and purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	8,849	8,638
Satellites, in process and not placed into service
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 22,900	$ 13,800

Balance Sheet Components - Sc_5

Balance Sheet Components - Schedule of Capitalized Software Development (Details) - USD ($) $ in Thousands	Apr. 30, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Capitalized internal-use software	$ 40,480	$ 39,535
Less: Accumulated amortization	(28,602)	(28,118)
Capitalized internal-use software, net	$ 11,878	$ 11,417

Balance Sheet Components - Sc_6

Balance Sheet Components - Schedule of Goodwill and Intangibles (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	$ 40,741	$ 40,489
Intangible assets, accumulated amortization	(27,026)	(25,927)
Intangible assets, foreign currency translation	284	269
Intangible assets, net carrying amount	13,999	14,831
Goodwill, gross carrying amount	110,942	110,942
Goodwill, foreign currency translation	1,806	1,806
Goodwill, net carrying amount	112,748	112,748
Goodwill, Accumulated Amortization	0	0
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	18,618	18,619
Intangible assets, accumulated amortization	(9,244)	(8,871)
Intangible assets, foreign currency translation	(8)	(8)
Intangible assets, net carrying amount	9,366	9,740
Image library
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	12,637	12,384
Intangible assets, accumulated amortization	(11,382)	(11,004)
Intangible assets, foreign currency translation	246	231
Intangible assets, net carrying amount	1,501	1,611
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	4,935	4,935
Intangible assets, accumulated amortization	(2,990)	(2,788)
Intangible assets, foreign currency translation	7	7
Intangible assets, net carrying amount	1,952	2,154
Trade names and other
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying amount	4,551	4,551
Intangible assets, accumulated amortization	(3,410)	(3,264)
Intangible assets, foreign currency translation	39	39
Intangible assets, net carrying amount	$ 1,180	$ 1,326

Balance Sheet Components - Accr

Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands		Apr. 30, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Deferred R&D service liability		$ 13,370	$ 19,959
Payroll and related expenses		4,609	8,518
Deferred hosting costs		4,772	4,694
Withholding taxes and other taxes payable		2,642	2,272
Other accruals		9,039	10,579
Total accrued and other current liabilities	[1]	$ 34,432	$ 46,022
[1]Balance includes related-party transactions entered into with Google, LLC (“Google”). See Note 10.

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Leases [Abstract]
Operating lease, cost	$ 2	$ 1.5
Operating lease, payments	1.1	2
Right of use assets obtained	$ 4.8	$ 0

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Details) $ in Thousands	Apr. 30, 2023 USD ($)
Leases [Abstract]
Remainder of Fiscal Year 2024	$ 5,965
2025	8,607
2026	8,371
2027	5,232
2028	1,206
Thereafter	857
Total lease payments	30,238
Less: Imputed interest	(4,006)
Total lease liabilities	$ 26,232
Weighted average remaining lease term (years)	3 years 9 months 18 days
Weighted average discount rate	7.90%

Research and Development Arra_2

Research and Development Arrangements (Details) $ in Thousands		1 Months Ended			3 Months Ended		12 Months Ended
		Apr. 30, 2023 satellite	Aug. 31, 2022 USD ($) satellite	Dec. 31, 2020 USD ($) yr	Apr. 30, 2023 USD ($)	Apr. 30, 2022 USD ($)	Jan. 31, 2023 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development expense incurred	[1]				$ 28,186	$ 24,750
Satellites
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Number of satellites | satellite		2	2
R&D Services Agreement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development arrangement, fee provided				$ 45,800
Research and development arrangement, milestone period | yr				3
Research and development fee recognized					4,000	2,800
Research and development expense incurred					4,000	$ 2,800
Proceeds from feeds received					36,900		$ 36,300
National Aeronautics Space Administration Communication Services Project
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Research and development fee recognized					3,100
Research and development expense incurred					3,900
Research and development arrangement funding receivable			$ 40,500
Funding for research and development					$ 6,500
[1]Balance includes related-party transactions entered into with Google. See Note 10.

Commitment and Contingencies -

Commitment and Contingencies - Purchase Commitments (Details) - Launch Service $ in Thousands	Apr. 30, 2023 USD ($)
Other Commitments [Line Items]
Remainder of Fiscal Year 2024	$ 475
Total purchase commitments	$ 475

Commitment and Contingencies _2

Commitment and Contingencies - Other Commitments (Details) $ in Thousands	Apr. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of Fiscal Year 2024	$ 19,802
2025	30,120
2026	31,190
2027	32,725
2028	33,427
Total purchase commitments	$ 147,264

Warrants (Details)

Warrants (Details)	Dec. 07, 2021 tradingDay $ / shares shares	Mar. 09, 2021 $ / shares shares	Apr. 30, 2023 $ / shares shares	Jan. 31, 2023 $ / shares shares
Class of Warrant or Right [Line Items]
Threshold trading days | tradingDay	20
2020 Convertible Notes
Class of Warrant or Right [Line Items]
Weighted average remaining term			6 years 10 months 24 days
Period 1
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	$ 15
Period 2
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	17
Period 3
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	19
Period 4
Class of Warrant or Right [Line Items]
Share price triggering share issuance (in dollars per share)	$ 21
Public Warrants
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) | shares			6,899,982	6,899,982
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) | shares	2,966,667		5,933,333	5,933,333
Weighted average remaining term	5 years
Private Placement Warrants, Vesting
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) | shares			2,966,667	2,966,667
Common Class A | Public Warrants
Class of Warrant or Right [Line Items]
Warrant exercise price (in dollars per share)		$ 11.50
Series D Convertible Preferred Stock | 2020 Convertible Notes
Class of Warrant or Right [Line Items]
Warrant outstanding (in shares) | shares			1,065,594	1,065,594
Series D Convertible Preferred Stock | 2020 Convertible Notes | Convertible Debt
Class of Warrant or Right [Line Items]
Warrant exercise price (in dollars per share)			$ 9.384	$ 9.384
dMY IV, LLC
Class of Warrant or Right [Line Items]
Equity units issued (in shares) | shares		34,500,000
dMY IV, LLC | Redeemable Warrant
Class of Warrant or Right [Line Items]
Equity units issued, shares called per unit (in shares) | shares		0.2
Warrant exercise price (in dollars per share)		$ 10
dMY IV, LLC | Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrant exercise price (in dollars per share)		$ 11.50
Warrant outstanding (in shares) | shares		5,933,333
Sale of stock, price per share (in dollars per share)		$ 1.50
dMY IV, LLC | Common Class A
Class of Warrant or Right [Line Items]
Equity units issued, shares called per unit (in shares) | shares		1

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2017	Jan. 31, 2023	Jun. 28, 2021
Related Party Transaction [Line Items]
Deferred revenue	$ 47,100
Deferred revenue, revenue recognized	25,100	$ 22,600
Deferred hosting costs	4,772			$ 4,694
Accounts payable and accrued liabilities	2,600			2,300
Google
Related Party Transaction [Line Items]
Related party transaction, agreement term			5 years
Related party transaction, renewal term			1 year
Purchase commitment					$ 193,000
Google | Content Licensing
Related Party Transaction [Line Items]
Deferred revenue				$ 300
Deferred revenue, revenue recognized	300	3,000
Google | Hosting and Other Services
Related Party Transaction [Line Items]
Related party costs and expenses	$ 6,400	$ 5,500
Common Class A
Related Party Transaction [Line Items]
Common stock, shares outstanding (in shares)	252,542,296			250,625,975
Google
Related Party Transaction [Line Items]
Deferred hosting costs	$ 15,400			$ 13,400
Google | PlanetLabs
Related Party Transaction [Line Items]
Ownership percentage (greater than)	10%			10%
Google | PlanetLabs | Common Class A
Related Party Transaction [Line Items]
Common stock, shares outstanding (in shares)	31,942,641			31,942,641

Stock-based Compensation - Sche

Stock-based Compensation - Schedule of Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	$ 15,983	$ 20,259
Capitalized to internal-use software development costs and property and equipment	(627)	(437)
Total stock-based compensation expense	15,356	19,822
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	917	1,319
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	6,585	8,666
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	3,080	3,637
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expense	$ 5,401	$ 6,637

Stock-based Compensation - Sc_2

Stock-based Compensation - Schedule of Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023
Number of Options
Outstanding, beginning balance (in shares)	33,721,774
Exercised (in shares)	(1,018,385)
Granted (in shares)	0
Forfeited (in shares)	(551,142)
Outstanding, ending balance (in shares)	32,152,247	33,721,774
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 5.08
Exercised (in dollars per share)	3.24
Granted (in dollars per share)	0
Forfeited (in dollars per share)	8.18
Outstanding, beginning balance (in dollars per share)	$ 5.09	$ 5.08
Outstanding, weighted average remaining term	6 years	6 years 3 months 18 days
Vested and exercisable, aggregate intrinsic value	$ 13,203
Vested and exercisable (in shares)	25,077,219
Vested and exercisable (in dollars per share)	$ 4.32
Vested and exercisable, weighted average remaining term	5 years 6 months
Vested and exercisable, aggregate intrinsic value	$ 13,088

Stock-based Compensation - Addi

Stock-based Compensation - Additional Information (Details) $ / shares in Units, $ in Thousands				3 Months Ended
	Apr. 24, 2023 shares	Dec. 13, 2021 shares	Dec. 07, 2021 tradingDay $ / shares	Apr. 30, 2023 USD ($) shares	Apr. 30, 2022 USD ($) shares	Jan. 31, 2023 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, options				$ 26,300
Share-based compensation expense				15,356	$ 19,822
Liability from early exercise of stock options				$ 11,653		$ 12,550
Unvested shares subject to repurchase (in shares) | shares				1,194,830
Threshold trading days | tradingDay			20
Threshold trading days range | tradingDay			30
VanderSat
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				8 months 12 days
Award vesting period				2 years
Share-based compensation expense				$ 600	600
Costs not yet recognized, award other than options				$ 1,600
Period 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) | $ / shares			$ 15
Period 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) | $ / shares			17
Period 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) | $ / shares			19
Period 4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price triggering share issuance (in dollars per share) | $ / shares			$ 21
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				2 years
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				3 years 3 months 18 days
Granted (in shares) | shares				15,709,449
Award vesting period				4 years
Share-based compensation expense				$ 9,400	8,500
Costs not yet recognized, award other than options				$ 127,000
Awards vested (in shares) | shares				1,278,161
Performance Vesting Restricted Stock Units (PSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				10 months 24 days
Granted (in shares) | shares	265,825
Costs not yet recognized, award other than options				$ 1,000
Performance Vesting Restricted Stock Units (PSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of PSU's eligible to vest				0%
Performance Vesting Restricted Stock Units (PSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of PSU's eligible to vest				125%
Earn-out Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Costs not yet recognized, period for recognition				6 months
Share-based compensation expense				$ 2,300	$ 7,100
Costs not yet recognized, award other than options				$ 2,800
Awards vested (in shares) | shares				0	0
Awards outstanding (in shares) | shares				4,108,375
Share-based Payment Arrangement | VanderSat | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Business combination, equity interests issued and issuable (in shares) | shares		543,391

Stock-based Compensation - Rest

Stock-based Compensation - Restricted Stock Unit Activity (Details) - Restricted Stock Units	3 Months Ended
	Apr. 30, 2023 $ / shares shares
Number of RSUs
Outstanding, beginning balance (in shares) | shares	16,972,601
Vested (in shares) | shares	(1,278,161)
Granted (in shares) | shares	15,709,449
Forfeited (in shares) | shares	(308,214)
Outstanding, ending balance (in shares) | shares	31,095,675
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 5.90
Vested (in dollars per share) | $ / shares	5.87
Granted (in dollars per share) | $ / shares	3.98
Forfeited (in dollars per share) | $ / shares	5.15
Outstanding, ending balance (in dollars per share) | $ / shares	$ 4.94

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ 307,000	$ 314,000
Unrecognized tax benefits	7,200,000		$ 6,900,000
Income tax examination, penalties and interest accrued	0		0
Income tax examination, penalties and interest expense	$ 0		$ 0

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Schedule of Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Numerator:
Net loss	$ (34,444)	$ (44,360)
Denominator:
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders, basic (in shares)	272,347,977	264,088,997
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders, diluted (in shares)	272,347,977	264,088,997
Basic and diluted net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.13)	$ (0.17)
Basic and diluted net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.13)	$ (0.17)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities (Details) - shares	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	104,975,317	95,845,788
Warrants to purchase Class A common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,065,594	1,065,594
Common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	32,152,247	38,924,582
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	31,095,675	13,949,577
Earn-out Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	25,567,385	26,172,277
dMY Sponsor Earn-out Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	862,500	862,500
Public Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	6,899,982	6,899,982
Private Placement Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	5,933,333	5,933,333
Early exercised common stock options, subject to future vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	1,194,830	1,562,476
Shares issued in connection with acquisition, subject to future vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	203,771	475,467

Uncategorized Items - pl-202304

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2016-13 [Member]